538837 — Jeevan Scientific Technology Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Jeevan Scientific Technology, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IAS	—	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	475	566	362	397	468
Cost of Revenue
Gross Profit	468	492	332	358	430
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	335	432	400	410	457
Operating Profit	139	134	-37.8	-13.1	11.6
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	136	183	-36.8	-16	0.507
Provision for Income Taxes
Net Income After Taxes	117	123	-30.6	-13.3	0.59
Minority Interest
Net Income Before Extraordinary Items
Net Income	117	123	-30.6	-13	1.34
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	117	123	-30.6	-13	1.34
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.67	8.15	-1.98	-0.837	0.085
Dividends per Share